Pfizer Can't Shake Investor Suit Over Off-Label Marketing

Law360, New York (August 10, 2011, 3:21 PM EDT) -- A New York federal judge refused Wednesday to dismiss a putative securities class action stemming from a $2.3 billion civil and criminal fine Pfizer Inc. paid for illegally marketing off-label uses of four drugs and offering doctors kickbacks to promote the medications.

The company had argued that the “plaintiffs’ prolix and confusing complaint — their third — [failed] to remedy the shortcomings identified” in an April order instructing them to refer only to certain exhibits necessary for the understanding of the allegations.

Pfizer pointed out that...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Jones et al v. Pfizer, Inc. et al


Case Number

1:10-cv-03864

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

Alvin K. Hellerstein

Date Filed

May 11, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.